Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Equity Ratio (2020 - 2025)

Pulse Biosciences has reported Equity Ratio over the past 6 years, most recently at 0.85 for Q3 2025.

  • Quarterly results put Equity Ratio at 0.85 for Q3 2025, changed 0.21% from a year ago — trailing twelve months through Sep 2025 was 0.85 (changed 0.21% YoY), and the annual figure for FY2024 was 0.87, up 15.63%.
  • Equity Ratio for Q3 2025 was 0.85 at Pulse Biosciences, down from 0.87 in the prior quarter.
  • Over the last five years, Equity Ratio for PLSE hit a ceiling of 0.89 in Q1 2025 and a floor of 0.15 in Q1 2023.
  • Median Equity Ratio over the past 5 years was 0.75 (2021), compared with a mean of 0.61.
  • Peak annual rise in Equity Ratio hit 2697.89% in 2023, while the deepest fall reached 128.88% in 2023.
  • Pulse Biosciences' Equity Ratio stood at 0.75 in 2021, then crashed by 103.85% to 0.03 in 2022, then skyrocketed by 2697.89% to 0.75 in 2023, then increased by 15.63% to 0.87 in 2024, then fell by 1.72% to 0.85 in 2025.
  • The last three reported values for Equity Ratio were 0.85 (Q3 2025), 0.87 (Q2 2025), and 0.89 (Q1 2025) per Business Quant data.